Psychiatric Medication, Practically

Why SNRIs Are Harder to Stop Than SSRIs

Save

SNRIs like venlafaxine and duloxetine tend to be harder to stop than SSRIs because they act on two neurotransmitter systems and often have shorter half-lives. This article explains both mechanisms and why planning ahead matters more with this specific medication class than with most others.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Are SNRIs really harder to stop than SSRIs, on average?

On average, yes -- discontinuation research describes SNRIs like venlafaxine and duloxetine as producing more pronounced and sometimes more frequent withdrawal symptoms than many SSRIs, though there's overlap and individual variation within both classes 1. This isn't true for every SNRI versus every SSRI in every case, but it's a consistent enough pattern across studies that it's treated as a real class-level difference in the clinical literature, not just a reputation earned from scattered anecdotes, which matters most when you're trying to plan realistically and specifically for your own situation.

What's the dual-neurotransmitter piece of this?

SNRIs act on both serotonin and norepinephrine, while SSRIs act primarily on serotonin alone. That means stopping an SNRI asks two neurotransmitter systems to readjust simultaneously rather than one, which is one proposed reason for the more pronounced symptom pattern described in discontinuation reviews 2. Norepinephrine is tied to alertness and the body's stress response, which may help explain why SNRI discontinuation is often described as including more noticeable physical agitation alongside the classic flu-like symptoms more typical of SSRI discontinuation on its own, according to comparative reviews of both drug classes.

Does half-life explain the rest of the difference?

Half-life adds to the picture. Venlafaxine and desvenlafaxine both have comparatively short half-lives among antidepressants, meaning blood levels drop faster after a dose is stopped or missed 3. The flu-like Cymbalta pattern and one missed day of Pristiq are both real examples of this fast-clearance effect showing up quickly and intensely -- the dual-neurotransmitter mechanism and the short half-life compound each other. Duloxetine sits in a similar range, which is part of why the SNRI class as a whole shows up so often in discontinuation research relative to how frequently it's prescribed.

Does this mean SNRIs are worse medications?

Not at all -- SNRIs are often prescribed specifically because they work well for a given person's depression, anxiety, or pain-related symptoms, and effectiveness and discontinuation profile are separate questions. A medication that's harder to stop isn't automatically a worse choice while you're taking it; it just means the stopping process, if and when it happens, deserves more planning than it might with some other medications 4. Many people take an SNRI for years without ever needing to stop, in which case this entire discontinuation profile is simply never relevant to their care.

Using this to plan ahead with your prescriber

Knowing that SNRIs carry a somewhat higher discontinuation burden on average is useful mainly for planning: it's a reason to never let your SNRI prescription run close to empty, and a reason to loop your prescriber in early if you're considering stopping rather than waiting until you're already uncomfortable. Staying ahead of psych med refills covers the practical side of avoiding an unplanned gap with exactly this kind of medication, where even a short delay at the pharmacy can turn into a genuinely uncomfortable few days rather than a minor inconvenience.

Common questions

Venlafaxine and desvenlafaxine (Pristiq) are frequently discussed in the research for their shorter half-lives and more pronounced discontinuation patterns; duloxetine (Cymbalta) is also commonly discussed for its fast-onset flu-like symptoms.

Not necessarily -- effectiveness for your specific condition and discontinuation profile are separate considerations, and an SNRI may still be the right medication for you even with a more involved stopping process down the line.

Norepinephrine is tied to alertness and the body's stress response, which is one proposed reason SNRI discontinuation is often described as including more physical agitation alongside typical flu-like symptoms.

Half-life varies within the class, and that's one factor your prescriber can weigh if discontinuation ease is a consideration when choosing or changing medications.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

If stopping an SNRI feels harder than expected

  • —Symptoms that are severe rather than merely uncomfortable
  • —Confusion, fainting, or a racing heart
  • —Symptoms not following a gradually improving pattern
  • —Thoughts of self-harm or suicide

Class-level patterns don't predict every individual's experience; some people stop SNRIs with minimal difficulty. This is general information, not medical advice. If you are in crisis, call or text 988 (Suicide & Crisis Lifeline), free and available 24/7.

References

  1. 1.Henssler J, Heinz A, Brandt L, Bschor T (2019). Antidepressant Withdrawal and Rebound Phenomena: A Systematic Review. Deutsches Arzteblatt International. doi:10.3238/arztebl.2019.0355 ✓antidepressant-withdrawalrebounddiscontinuation-syndrome
  2. 2.Fava GA, Gatti A, Belaise C, Guidi J, Offidani E (2015). Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review. Psychotherapy and Psychosomatics. doi:10.1159/000370338 ✓antidepressant-discontinuationssri-withdrawaldiscontinuation-syndrome
  3. 3.Cosci F, Chouinard G (2020). Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications. Psychotherapy and Psychosomatics. doi:10.1159/000506868 ✓withdrawal-syndromepsychotropic-discontinuationprotracted-withdrawal
  4. 4.Davies J, Read J (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?. Addictive Behaviors. doi:10.1016/j.addbeh.2018.08.027 ✓antidepressant-withdrawalwithdrawal-durationguidelines

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library